These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34459696)

  • 1. Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients.
    Tan T; Bunnapradist S
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1175-1186. PubMed ID: 34459696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
    Fontova P; Colom H; Rigo-Bonnin R; Bestard O; Vidal-Alabró A; van Merendonk LN; Cerezo G; Polo C; Montero N; Melilli E; Manonelles A; Meneghini M; Coloma A; Cruzado JM; Torras J; Grinyó JM; Lloberas N
    Clin Pharmacol Ther; 2021 Jul; 110(1):238-247. PubMed ID: 33626199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients.
    Bae EK; Chandran MM; Everitt MD; Benz E; Bock M
    Clin Transplant; 2024 Aug; 38(8):e15417. PubMed ID: 39087462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of the conversion to MeltDose
    Sánchez Fructuoso A; Ruiz JC; Franco A; Diekmann F; Redondo D; Calviño J; Serra N; Aladrén MJ; Cigarrán S; Manonelles A; Ramos A; Gómez G; González Posada JM; Andrés A; Beneyto I; Muñiz AL; Perelló M; Lauzurica R
    Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.
    Herden U; Sterneck M; Buchholz BM; Achilles EG; Ott A; Fischer L
    Immun Inflamm Dis; 2021 Dec; 9(4):1771-1780. PubMed ID: 34559956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
    Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial.
    Suwelack B; Bunnapradist S; Meier-Kriesche U; Stevens DR; Procaccianti C; Morganti R; Budde K
    Ann Transplant; 2020 Jul; 25():e923278. PubMed ID: 32719307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Envarsus in pediatric kidney transplant recipients - phase 1 pilot conversion study.
    Kim JJ; Lawless L; Marshall D; Maxted A; Lunn A; Mallik M; Williams A
    Pediatr Transplant; 2024 Mar; 28(2):e14703. PubMed ID: 38433334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
    Giral M; Grimbert P; Morin B; Bouvier N; Buchler M; Dantal J; Garrigue V; Bertrand D; Kamar N; Malvezzi P; Moreau K; Athea Y; Le Meur Y
    Transpl Int; 2024; 37():11571. PubMed ID: 38694490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients.
    Choi D; Thaker S; West-Thielke P; Elmasri A; Chan C
    Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1124-1128. PubMed ID: 34213506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
    Faravardeh A; Akkina S; Villicana R; Guerra G; Moten MA; Meier-Kriesche U; Stevens DR; Patel SJ; Bunnapradist S
    Ann Transplant; 2021 Apr; 26():e929535. PubMed ID: 33859155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study.
    January SE; Hagopian JC; Nesselhauf NM; Progar K; Horwedel TA; Santos RD
    Drugs Aging; 2021 May; 38(5):397-406. PubMed ID: 33755934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation.
    Rubik J; Debray D; Iserin F; Vondrak K; Sellier-Leclerc AL; Kelly D; Czubkowski P; Webb NJA; Riva S; D'Antiga L; Marks SD; Rivet C; Tönshoff B; Kazeem G; Undre N
    Pediatr Transplant; 2019 Jun; 23(4):e13391. PubMed ID: 30932313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis.
    Saengram W; Vadcharavivad S; Poolsup N; Chancharoenthana W
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1249-1260. PubMed ID: 29961086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus.
    Taber DJ; Bartlett F; Patel N; Sprague T; Patel S; Newman J; Andrade E; Rao N; Salas MAP; Casey M; Dubay D; Rohan V
    Clin Transplant; 2023 May; 37(5):e14941. PubMed ID: 36809653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.